Amgen To Present At The Morgan Stanley Global Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Cantor Fitzgerald Reiterates Neutral Rating on Amgen (AMGN)
September 9, 2019 7:03 AM EDTCantor Fitzgerald analyst Alethia Young reiterated a Neutral rating and $230.00 price target on Amgen (NASDAQ: AMGN) after the company presented updated AMG-510 data at the World Lung medical meeting and hosted a conference call to discuss the data. This update included an additional... More
